These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6766575)

  • 21. [Pathologic and hemodynamic observation on the glutaraldehyde-preserved porcine aortic valve implanted in the tricuspid and pulmonary position].
    Okamura K; Yuge I; Iriyama T; Kawazoe K; Kurosawa H
    Nihon Kyobu Geka Gakkai Zasshi; 1975 Jul; 23(7):911-21. PubMed ID: 811740
    [No Abstract]   [Full Text] [Related]  

  • 22. Biological factors affecting long-term results of valvular heterografts.
    Carpentier A; Lemaigre G; Robert L; Carpentier S; Dubost C
    J Thorac Cardiovasc Surg; 1969 Oct; 58(4):467-83. PubMed ID: 5344189
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experimental study and clinical observations on glutaraldehyde-treated skin grafts].
    Wu XQ
    Zhonghua Wai Ke Za Zhi; 1984 Aug; 22(8):461-3, 509. PubMed ID: 6440761
    [No Abstract]   [Full Text] [Related]  

  • 24. [An Experimental study of conduit graft containing 1.3% dialdehyde starch treated porcine aortic xenograft valve].
    Nihei K
    Nihon Kyobu Geka Gakkai Zasshi; 1982 Jun; 30(6):1090-101. PubMed ID: 6816868
    [No Abstract]   [Full Text] [Related]  

  • 25. [Specific features of the structure of the porcine aortic valve as a potential xenograft for the substitution of the human aorta valve].
    Gavrilenkov VI
    Vestn Khir Im I I Grek; 2004; 163(3):28-34. PubMed ID: 15317157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concentration of glutaraldehyde in fixation of bioprosthetic valves.
    Chanda J; Kuribayashi R; Abe T
    J Thorac Cardiovasc Surg; 1997 Sep; 114(3):512-3. PubMed ID: 9305216
    [No Abstract]   [Full Text] [Related]  

  • 27. Early stenosis and calcification of glutaraldehyde-preserved porcine xenografts in children.
    Hellberg K; Ruschewski W; de Vivie ER
    Thorac Cardiovasc Surg; 1981 Dec; 29(6):369-74. PubMed ID: 6179219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic pattern of the pig aortic valve and its simplification by culture and transplantation.
    Durán CM; Teijeira J
    Rev Esp Fisiol; 1973 Dec; 29(4):273-8. PubMed ID: 4598509
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sterilization of biologic heart valve prostheses with glutardialdehyde].
    Sprössig M; Wutzler P; Mücke H; Wenzel KP
    Z Exp Chir; 1973; 6(4):248-51. PubMed ID: 4204074
    [No Abstract]   [Full Text] [Related]  

  • 30. The basis for selecting a valve prosthesis.
    Bonchek LI
    Cardiovasc Clin; 1981; 12(3):103-15. PubMed ID: 6805954
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental evaluation of aortic homograft valves mounted on flexible support frames and comparison with glutaraldehyde-treated porcine valves.
    Pohlner PG; Thomson FJ; Hjelms E; Barratt-Boyes BG
    J Thorac Cardiovasc Surg; 1979 Feb; 77(2):287-93. PubMed ID: 762970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of glutaraldehyde preparations on the properties of biological heart valve prostheses].
    Vrsanský D
    Bratisl Lek Listy; 1991 Jul; 92(7):352-4. PubMed ID: 1913202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fate of xenogenic formaldehyde-treated aortic valve replacements].
    Wenzel KP; Brähne I; Buchholz I; Pannwitz HG; Panzner R; Stintz AR; Stintz S
    Z Exp Chir; 1972; 5(3):158-67. PubMed ID: 4618953
    [No Abstract]   [Full Text] [Related]  

  • 34. Structural changes in glutaraldehyde-treated porcine heterografts used as substitute cardiac valves. Transmission and scanning electron microscopic observations in 12 patients.
    Ferrans VJ; Spray TL; Billingham ME; Roberts WC
    Am J Cardiol; 1978 Jun; 41(7):1159-84. PubMed ID: 96684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic assessment of the glutaraldehyde-preserved porcine heterograft in the aortic and mitral positions.
    Lurie AJ; Miller RR; Maxwell KS; Grehl TM; Vismara LA; Hurley EJ; Mason DT
    Circulation; 1977 Sep; 56(3 Suppl):II104-10. PubMed ID: 407031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valvular xenograft and valvular xenobioprosthesis: past, present, future.
    Carpentier A
    Nihon Kyobu Geka Gakkai Zasshi; 1979 Apr; 27(4):397-404. PubMed ID: 469294
    [No Abstract]   [Full Text] [Related]  

  • 37. Improved ultrastructural preservation of bioprosthetic tissue.
    Zilla P; Zhang Y; Human P; Koen W; von Oppell U
    J Heart Valve Dis; 1997 Sep; 6(5):492-501. PubMed ID: 9330171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Porcine heterografts in tricuspid position.
    Horowitz MS
    Am J Cardiol; 1978 Oct; 42(4):691. PubMed ID: 696652
    [No Abstract]   [Full Text] [Related]  

  • 39. Non-Cytotoxic Crosslinkers for Heart Valve Tissue Engineering.
    Somers P; Roosens A; De Somer F; Cornelissen M; Van Nooten G
    J Heart Valve Dis; 2015 Jan; 24(1):92-100. PubMed ID: 26182626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiovalvular immunology].
    Lledías Ferro T
    Rev Med Univ Navarra; 1972 Sep; 16(3):227-39. PubMed ID: 4671429
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.